Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - 25 Studies Found
Completed |
: Campath-1H for Treating Adult T-Cell Leukemia/Lymphoma : Acute T-Cell Leukemia-Lymphoma : 2003-05-20 : Biological: Alemtuzumab Infusion of Campath-1H 3 mg on day # 1, 10 mg on day #2, and 30 mg day # 3 follo |
Completed |
: Studying Samples From Patients With T-Cell Acute Lymphoblastic Leukemia : Leukemia : 2012-04-19 :
|
Completed |
: DNA Analysis of Tissue From Patients With T-Cell Acute Lymphoblastic Leukemia : Leukemia : 2009-05-09 :
|
Completed |
: Studying RNA in Samples From Younger Patients With T-Cell Acute Lymphoblastic Leukemia : Leukemia : 2012-06-20 :
|
Completed |
: Biomarker Study in Bone Marrow Samples From Patients With T-Cell Acute Lymphoblastic Leukemia : Leukemia : 2011-02-11 :
|
Terminated |
: A Notch Signalling Pathway Inhibitor for Patients With T-cell Acute Lymphoblastic Leukemia/Lymphoma (ALL)(0752-013) :
: 2005-09-12 :
|
Terminated |
: Study of Forodesine Hydrochloride in Patients With Relapsed/Refractory Precursor T-Lymphoblastic Leukemia/Lymphoma Who Have Failed Two or More Prior Treatment Regimens :
: 2007-01-05 :
|
Completed |
: 506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma :
: 1999-11-01 : Drug: nelarabine |
Recruiting |
: Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma :
|